One year ago, we launched a bold experiment: What if there was a real social network for business leaders? No self-promo. No influencer fluff. Just verified operators helping each other win. Now? 20,000+ verified members. But that’s not what I’m most proud of...

Father’s Day scramble. You guys know what that means. Time to bring out the big guns

👀

Officially official - Ascension is acquiring AmSurg! I broke down the details here and discussed Ascension's health system transformation strategy as well: hospitalogy.com/articles/2025-… Link to press release: globenewswire.com/news-release/2…

Nabla, an AI scribe player, announced a huge $70M Series C today! Since launching in 2018, Nabla has: • Raised a total of $120M • Been adopted by 85,000+ clinicians at 130+ healthcare organizations • Saved clinicians an average of 2 hours daily

Notable (non-exhaustive) health tech funding, week of 6/17

$5.3B: Abridge's current valuation after its $300M raise today. The AI scribe space is red-hot, and Abridge is at the forefront. A short history of Abridge shows you just how quickly they've scaled amid rampant clinician adoption:

Health Tech funding, week of 6.26.25: • Artisight • Mandolin • Certify • EnsoData • ForSight Robotics • SuperDial • Abridge • Visby Medical • Glytec • Commure • Veracity • Tennr • Mealogic • Lyrebird Health • Quilt Health Follow me Blake Madden 🏥 for more!

Is this a signal that value-based care is becoming the new normal? Today, about 60% of US healthcare payments are tied to value and quality. That feels like progress. Watch this clip with Pranam Ben The Garage and see if you agree.

Just pulled up the strategy section of the Beckers and 7/10 of the articles on page 1 are sponsored. I mean I get the business but that's insane. I get terrified of diluting my content quality every time I send a sponsored post 😂

👀

Nabla and Navina partnership integrates Nabla's AI medical scribe with Navina's AI-enabled copilot for broader AI capabilities across clinical workflows. Nabla @navina_ai fiercehealthcare.com/health-tech/na…

There’s a gap between what AI vendors are pitching and what health systems need. What will close it? Members: Watch the replay with Raihan Faroqui of Guaranteed: boardroom.hospitalogy.com/library/5f4e87… Or join for access: boardroom.hospitalogy.com/feed Raihan Faroqui Guaranteed

NEW: OpenEvidence, the AI medical assistant, just raised $210M at a $3.5B valuation led by GV & Kleiner Perkins. Now used by 40% of US doctors, it handles 8.5M clinical consults/month. The company also launched DeepConsult, an AI agent for PhD-level evidence syntheses.

February 19, 2025: • OpenEvidence is worth 10% of Doximity July 15, 2025: • OpenEvidence is now worth 33% of Doximity (on paper)

Pretty interesting to compare these two Medicare Advantage datapoints: • people have access to choose from 50+ plans • most MA markets are highly concentrated So seniors are all choosing the same plans - unless I'm missing something here?

This was a great overview from PwC on the numbers behind medical cost trends. Read it here: pwc.com/us/en/industri…